Pharming Group Competitors and Similar CompaniesClear all

Protalix BioTherapeutics's competitors and similar companies include Strategic Partners.
Protalix BioTherapeutics
Protalix BioTherapeutics
Protalix is a biopharmaceutical company focused on the development, production, and commercialization of recombinant therapeutic proteins.
Strategic Partners
Strategic Partners
Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies.
Founding Date
Founding Date
1994
Founding Date
2009
Type
Type
Public
Type
Public
Tags
Locations
Locations
Karmiel, IL HQ
Locations
København, DK HQ
Chicago, US
Newton, US
Employees
Employees
213
Employees
1

Financial

Revenue (est.)
Revenue (est.)
$52.7m (FY, 2025)
Revenue (est.)
kr309k (FY, 2025)
Cost of goods
Cost of goods
$25.5m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
$27.2m (FY, 2025)
Gross profit
kr309k (FY, 2025)
Net income
Net income
($6.6m) (FY, 2025)
Net income
(kr859k) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 62.5m
Total funding raised
$ 58.8m
For sources of this data, please see the company profile

View Company Profiles

Strategic Partners
HQ
København, DK
Employees
1

Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies.

View company